AJR Join ARRS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gervais, D. A.
Right arrow Articles by Mueller, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gervais, D. A.
Right arrow Articles by Mueller, P. R.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
DOI:10.2214/AJR.05.1106
AJR 2006; 187:746-750
© American Roentgen Ray Society

Clinical Observations

Percutaneous Radiofrequency Ablation of Ovarian Cancer Metastasis to the Liver: Indications, Outcomes, and Role in Patient Management

Debra A. Gervais1, Ronald S. Arellano1 and Peter R. Mueller1

1 All authors: Department of Radiology, Massachusetts General Hospital, 55 Fruit St., White 270, Boston, MA 02114.

OBJECTIVE. Stages III and IV ovarian cancer are treated with a combination of chemotherapy and resection, in some cases including second and third surgical procedures, to achieve cytoreduction. Percutaneous radiofrequency ablation has proved effective in local control of hepatic tumors. We report early experience with percutaneous radiofrequency ablation in the management of isolated foci of metastatic ovarian cancer and assess the efficacy of the technique in achieving and maintaining local control by percutaneous cytoreduction.

CONCLUSION. Percutaneous radiofrequency ablation is effective in achieving local control in selected patients with metastasis from ovarian cancer. In patients with limited macroscopic disease, cytoreduction can be achieved without surgery.

Keywords: oncology • ovarian neoplasm • percutaneous ablation • radiofrequency ablation


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Roentgen Ray Society.